EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive

The MC held in Madrid on 13 April 2013 was a great success.

We had the honour to have with us some highly qualified speakers who specialise in personalised medicine. Also the ethical implications of personalised medicine were discussed in depth.

In order to make future Masterclasses even more useful for members, but also to motivate and increase the number of participant, MPE will be sending out an evaluation form to all members.







Recent news

» EHA 2021| Daratumumab plus lenalidomide and dexamethasone (D-Rd) shows overall survival benefit in elderly patients with transplant-ineligible newly diagnosed myeloma

» EHA 2021 | Daratumumab maintenance improves Progression-Free Survival (PFS) after autologous stem cell transplantation in myeloma

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.